CompletedNot Applicable

Prevalence of Postpartum Depression Among Patients of the CHUM GARE Clinic

Canada100 participantsStarted 2025-10-20

Plain-language summary

Postpartum depression (PPD) is a frequent complication of the postnatal period but remains underdetected in routine clinical practice. This prospective clinical study, conducted at the high-risk pregnancy clinic of the CHUM, aims to estimate the prevalence of PPD among patients seen in postpartum follow-up. It also assesses the feasibility of implementing a standardized screening protocol that combines the administration of the Edinburgh Postnatal Depression Scale (EPDS) with a clinical decision-support algorithm to guide appropriate medical follow-up. The study also seeks to explore clinical characteristics associated with higher EPDS scores.

Who can participate

Age range

18 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients aged 18 years or more * Patient who gave birth within the last 4 weeks to 6 months * Ability to understand French or English and complete the EPDS questionnaire * Physically present at their post-partum visit at the clinic Exclusion Criteria: * Inability to comprehend and/or complete the EPDS * Declines participation or does not provide informed consent

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1This study was completed and was measuring how common postpartum depression is among patients at the CHUM GARE Clinic — has that data been published yet, and could it tell us anything about my own risk level?
2Since this was an observational study measuring prevalence rather than testing a treatment, does it offer any direct benefit to me, or would my doctor recommend I look into a treatment-focused study or therapy program instead?
3The study focused on a specific clinic population — how well do those findings apply to my situation, given that my background or care setting might be different from the CHUM GARE patient group?
4Because postpartum depression can vary a lot depending on personal risk factors, what screening tools or assessments does my doctor currently use to evaluate me, beyond what this study may have looked at?
5Given that this study has already been completed, are there any follow-up studies or clinical programs at the same centre that I might be eligible to discuss with my care team?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Prevalence of postpartum depression in the study population

Timeframe: Baseline EPDS score (Day 0)

Trial details

NCT IDNCT07200323

SponsorCentre hospitalier de l'Université de Montréal (CHUM)

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-03-18

View on ClinicalTrials.gov More Post-partum Depression trials